- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03103204
Treatment of Periodontitis in Obese Individuals (CLIMBEO)
Clinical, Microbial and Biochemistry Evaluation of Obese Individuals Submitted to One-stage Full-mouth Disinfection. A Clinical Control Parallel Study
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
Sao Paulo
-
Taubate, Sao Paulo, Brazil, 12020330
- University of Taubate
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Moderate to advanced generalized chronic periodontitis
- Body mass index: > 18.5 kg/m2
- Minimum of 12 natural teeth
- Smokers, non-smokers or former-smokers
Exclusion Criteria:
- Systemic diseases (diabetes, renal diseases, rheumatic diseases, osteoporosis and cardiovascular diseases)
- Pregnant and lactating women
- HIV/ AIDS
- periodontal treatment in the last year (before baseline appointment)
- Medication: Immunosuppressive drugs, antibiotics in the past three months (before baseline appointment) )
- orthodontic appliance
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Normal weight full-mouth disinfection
|
Mechanical procedures, composed of full-mouth dental scaling and root planning and dental prophylaxis, will be completed within 24 hours (2 appointments in 2 consecutive mornings or afternoons). Chlorhexidine will be used as the antimicrobial agent in different concentrations (0.2%, 1% and 2%) and vehicles (solution, gel). Oral hygiene instructions will be given for all participants. |
|
Experimental: Overweight full-mouth disinfection
|
Mechanical procedures, composed of full-mouth dental scaling and root planning and dental prophylaxis, will be completed within 24 hours (2 appointments in 2 consecutive mornings or afternoons). Chlorhexidine will be used as the antimicrobial agent in different concentrations (0.2%, 1% and 2%) and vehicles (solution, gel). Oral hygiene instructions will be given for all participants. |
|
Experimental: Obesity I full-mouth disinfection
|
Mechanical procedures, composed of full-mouth dental scaling and root planning and dental prophylaxis, will be completed within 24 hours (2 appointments in 2 consecutive mornings or afternoons). Chlorhexidine will be used as the antimicrobial agent in different concentrations (0.2%, 1% and 2%) and vehicles (solution, gel). Oral hygiene instructions will be given for all participants. |
|
Experimental: Obesity II full-mouth disinfection
|
Mechanical procedures, composed of full-mouth dental scaling and root planning and dental prophylaxis, will be completed within 24 hours (2 appointments in 2 consecutive mornings or afternoons). Chlorhexidine will be used as the antimicrobial agent in different concentrations (0.2%, 1% and 2%) and vehicles (solution, gel). Oral hygiene instructions will be given for all participants. |
|
Experimental: Obesity III full-mouth disinfection
|
Mechanical procedures, composed of full-mouth dental scaling and root planning and dental prophylaxis, will be completed within 24 hours (2 appointments in 2 consecutive mornings or afternoons). Chlorhexidine will be used as the antimicrobial agent in different concentrations (0.2%, 1% and 2%) and vehicles (solution, gel). Oral hygiene instructions will be given for all participants. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Periodontal clinical efficacy
Time Frame: Changes in periodontal pocket depth measurements from baseline to 6 months
|
Improvements in periodontal pocket depth (mm) overtime and comparisons among groups at 6 months after treatment
|
Changes in periodontal pocket depth measurements from baseline to 6 months
|
|
Periodontal clinical efficacy
Time Frame: Changes in clinical attachment measurements from baseline to 6 months
|
Improvements in clinical attachment level (mm) overtime and comparisons among groups at 6 months after treatment
|
Changes in clinical attachment measurements from baseline to 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Antimicrobial efficacy
Time Frame: Changes in total bacterial levels from baseline to 6 months
|
Reductions in total bacterial levels and levels of target bacterial species overtime and comparisons among groups at 6 months after treatment
|
Changes in total bacterial levels from baseline to 6 months
|
|
Antimicrobial efficacy
Time Frame: Changes in bacterial levels from baseline to 6 months
|
Reductions in Treponema denticola, Porphyromonas gingivalis, Tannerella forsythia, Aggregatibacter actinomycetemcomitans levels overtime and comparisons among groups at 6 months after treatment
|
Changes in bacterial levels from baseline to 6 months
|
|
Oral safety and tolerability
Time Frame: Changes in salivary nitrite levels from baseline to 6 months
|
Maintenance of salivary nitrite levels overtime and comparisons among groups at 6 months after treatment
|
Changes in salivary nitrite levels from baseline to 6 months
|
|
Impact on quality of life
Time Frame: Changes in scores (Likert scale ranging from 16 to 80 points) of Oral health and quality of life - United Kingdom questionnaire from baseline to 6 months
|
Improvements in Oral health and quality of life - United Kingdom questionnaire scores overtime and comparisons among groups at 6 months after treatment
|
Changes in scores (Likert scale ranging from 16 to 80 points) of Oral health and quality of life - United Kingdom questionnaire from baseline to 6 months
|
|
Impact on quality of life
Time Frame: Changes in scores (Likert scale ranging from 0 to 56 points) of Oral impacts on daily performance questionnaire from baseline to 6 months
|
Improvements in Oral impacts on daily performance questionnaire scores overtime and comparisons among groups at 6 months after treatment
|
Changes in scores (Likert scale ranging from 0 to 56 points) of Oral impacts on daily performance questionnaire from baseline to 6 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Systemic effects
Time Frame: Changes in in glycemic levels from baseline to 6 months.
|
Glycemic blood levels.
|
Changes in in glycemic levels from baseline to 6 months.
|
|
Systemic effects
Time Frame: Changes in blood levels of high density lipoprotein-cholesterol, low density lipoprotein -cholesterol and very low density lipoprotein - fractions from baseline to 6 months.
|
Blood levels of high density lipoprotein-cholesterol, low density lipoprotein -cholesterol, very low density lipoprotein - fractions levels parameters.
|
Changes in blood levels of high density lipoprotein-cholesterol, low density lipoprotein -cholesterol and very low density lipoprotein - fractions from baseline to 6 months.
|
|
Systemic effects
Time Frame: Changes in blood counts of white cells, red cells and platelets from baseline to 6 months.
|
Blood counts of white cells, red cells and platelets.
|
Changes in blood counts of white cells, red cells and platelets from baseline to 6 months.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jose R Cortelli, PhD, Associate professor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- UTaubate
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Periodontitis
-
Mahsa UniversityRecruitingPeriodontitis | Periodontitis Chronic Generalized Moderate | Periodontitis (Stage 3) | Periodontitis, Adult | Periodontitis Chronic Generalized Severe | Periodontitis, Chronic | Periodontitis Stage II | Periodontitis Chronic Localized Slight | Periodontitis Stage IIIMalaysia
-
Shanghai Ninth People's Hospital Affiliated to...Not yet recruitingPeriodontitis Stage II | Periodontitis Stage III | Periodontitis Stage IV
-
Misr University for Science and TechnologyCompletedPeriodontitis | Periodontitis Stage I | Periodontitis Stage II | Periodontitis Stage IIIEgypt
-
Cairo UniversityRecruitingPeriodontitis | Periodontitis Stage II | Periodontitis Stage IIIEgypt
-
Ataturk UniversityCompletedPeriodontitis | Periodontitis Stage I | Periodontitis Stage IITurkey (Türkiye)
-
Al-Azhar UniversityNot yet recruitingStage IV Periodontitis | Advanced Periodontitis | Stage III PeriodontitisEgypt
-
Panineeya Mahavidyalaya Institute of Dental Sciences...Research Institute for Genetic and Human TherapyUnknownGeneralized Adult Periodontitis
-
Duygu DegirmenciogluNot yet recruitingApical PeriodontitisTurkey (Türkiye)
-
University of ZagrebActive, not recruitingApical PeriodontitisCroatia
-
Hilal Çuhadar BeşiroğluCompletedApical PeriodontitisTurkey (Türkiye)
Clinical Trials on One-stage full-mouth disinfection with chlorhexidine
-
First Affiliated Hospital, Sun Yat-Sen UniversityCompletedPrehypertension | Chronic PeriodontitisChina
-
Universidad del Valle, ColombiaCompleted
-
Centro Universitario de LavrasFederal University of Minas GeraisCompletedChronic Periodontitis | Periodontal DiseaseBrazil
-
University of CataniaCompleted
-
Aydin Adnan Menderes UniversityCompletedChronic Periodontitis
-
University of SienaNot yet recruitingPeriodontitis, AdultItaly
-
University of SienaRecruitingPeriodontitis, AdultItaly
-
Federal University of Minas GeraisCompleted
-
University of Campinas, BrazilRecruitingPeriodontal Diseases | Microbial Colonization | Periodontal InflammationBrazil